banni.id

First-time postmenopausal bleeding as a clinical marker of long-term cancer risk: A Danish Nationwide Cohort Study

4.6 (542) · $ 27.50 · In stock

First-time postmenopausal bleeding as a clinical marker of long-term cancer risk: A Danish Nationwide Cohort Study

Unusual Cancers of Childhood Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf

Mette NØRGAARD, Aarhus University Hospital, Århus, AUH, Department of Clinical Epidemiology

Endometriosis-associated Ovarian Clear Cell Carcinoma: A Special Entity?

Predicting the risk of endometrial cancer in postmenopausal women presenting with vaginal bleeding: the Norwich DEFAB risk assessment tool

Research articles British Journal of Cancer

Ovarian Cancer: Practice Essentials, Background, Pathophysiology

First-time postmenopausal bleeding as a clinical marker of long-term cancer risk: A Danish Nationwide Cohort Study

Traditional and Emerging Sex-Specific Risk Factors for Cardiovascular Disease in Women

PDF) Outcome in terms of histological diagnosis in patients with postmenopausal bleeding

ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma

Elevated risk thresholds predict endocrine risk-reducing medication use in the Athena screening registry

© 2018-2024, banni.id, Inc. or its affiliates